Journal
BRIEFINGS IN BIOINFORMATICS
Volume 22, Issue 6, Pages -Publisher
OXFORD UNIV PRESS
DOI: 10.1093/bib/bbab241
Keywords
immunoinformatics; mutations; SARS-CoV-2; vaccine
Funding
- Shahid Beheshti University, G.C., Tehran, Iran [SAD/600/1451]
- Center for High Performance Computing at Shahid Beheshti University of Iran
Ask authors/readers for more resources
Immunoinformatics plays a crucial role in the development of vaccines and drugs for combating SARS-CoV-2 by extracting meaningful connections from COVID-19 patient data to design effective preventive measures.
With the onset of the COVID-19 pandemic, the amount of data on genomic and proteomic sequences of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) stored in various databases has exponentially grown. A large volume of these data has led to the production of equally immense sets of immunological data, which require rigorous computational approaches to sort through and make sense of. Immunoinformatics has emerged in the recent decades as a field capable of offering this approach by bridging experimental and theoretical immunology with state-of-the-art computational tools. Here, we discuss how immunoinformatics can assist in the development of high-performance vaccines and drug discovery needed to curb the spread of SARS-CoV-2. Immunoinformatics can provide a set of computational tools to extract meaningful connections from the large sets of COVID-19 patient data, which can be implemented in the design of effective vaccines. With this in mind, we represent a pipeline to identify the role of immunoinformatics in COVID-19 treatment and vaccine development. In this process, a number of free databases of protein sequences, structures and mutations are introduced, along with docking web servers for assessing the interaction between antibodies and the SARS-CoV-2 spike protein segments as most commonly considered antigens in vaccine design.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available